133 related articles for article (PubMed ID: 17297458)
1. Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells.
Miller SL; Antico G; Raghunath PN; Tomaszewski JE; Clevenger CV
Oncogene; 2007 Jul; 26(32):4668-78. PubMed ID: 17297458
[TBL] [Abstract][Full Text] [Related]
2. Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor.
Miller SL; DeMaria JE; Freier DO; Riegel AM; Clevenger CV
Mol Endocrinol; 2005 Apr; 19(4):939-49. PubMed ID: 15618286
[TBL] [Abstract][Full Text] [Related]
3. Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.
Harrington KM; Clevenger CV
J Biol Chem; 2016 Oct; 291(41):21388-21406. PubMed ID: 27489110
[TBL] [Abstract][Full Text] [Related]
4. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
Hammer A; Diakonova M
BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
[TBL] [Abstract][Full Text] [Related]
5. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.
Wang H; Quah SY; Dong JM; Manser E; Tang JP; Zeng Q
Cancer Res; 2007 Apr; 67(7):2922-6. PubMed ID: 17409395
[TBL] [Abstract][Full Text] [Related]
6. Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.
Hammer A; Diakonova M
Adv Exp Med Biol; 2015; 846():97-137. PubMed ID: 25472536
[TBL] [Abstract][Full Text] [Related]
7. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
[TBL] [Abstract][Full Text] [Related]
8. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma.
McHale K; Tomaszewski JE; Puthiyaveettil R; Livolsi VA; Clevenger CV
Mod Pathol; 2008 May; 21(5):565-71. PubMed ID: 18246042
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1.
Salhia B; Rutten F; Nakada M; Beaudry C; Berens M; Kwan A; Rutka JT
Cancer Res; 2005 Oct; 65(19):8792-800. PubMed ID: 16204049
[TBL] [Abstract][Full Text] [Related]
11. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
12. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
Nouhi Z; Chughtai N; Hartley S; Cocolakis E; Lebrun JJ; Ali S
Cancer Res; 2006 Feb; 66(3):1824-32. PubMed ID: 16452244
[TBL] [Abstract][Full Text] [Related]
13. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF
Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613
[TBL] [Abstract][Full Text] [Related]
14. Prolactin as a chemoattractant for human breast carcinoma.
Maus MV; Reilly SC; Clevenger CV
Endocrinology; 1999 Nov; 140(11):5447-50. PubMed ID: 10537179
[TBL] [Abstract][Full Text] [Related]
15. EHD2 mediates trafficking from the plasma membrane by modulating Rac1 activity.
Benjamin S; Weidberg H; Rapaport D; Pekar O; Nudelman M; Segal D; Hirschberg K; Katzav S; Ehrlich M; Horowitz M
Biochem J; 2011 Nov; 439(3):433-42. PubMed ID: 21756249
[TBL] [Abstract][Full Text] [Related]
16. Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin A.
Hammer A; Rider L; Oladimeji P; Cook L; Li Q; Mattingly RR; Diakonova M
Mol Endocrinol; 2013 Mar; 27(3):455-65. PubMed ID: 23340249
[TBL] [Abstract][Full Text] [Related]
17. PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.
Rider L; Oladimeji P; Diakonova M
Mol Endocrinol; 2013 Jul; 27(7):1048-64. PubMed ID: 23744893
[TBL] [Abstract][Full Text] [Related]
18. Rac1 mediates phorbol 12-myristate 13-acetate-induced migration of glioblastoma cells via paxillin.
Nomura N; Nomura M; Mizuki N; Hamada J
Oncol Rep; 2008 Oct; 20(4):705-11. PubMed ID: 18813807
[TBL] [Abstract][Full Text] [Related]
19. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
[TBL] [Abstract][Full Text] [Related]
20. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
